Pages that link to "Q33415842"
Jump to navigation
Jump to search
The following pages link to A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma (Q33415842):
Displaying 5 items.
- Extracellular signal-regulated kinase 1 and 2 in cancer therapy: a focus on hepatocellular carcinoma. (Q35894374) (← links)
- Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib (Q38627885) (← links)
- Sunitinib in kidney cancer: 10 years of experience and development. (Q39038214) (← links)
- How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive. (Q52668325) (← links)
- Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer (Q92512964) (← links)